EMBC

Embecta Corp. Healthcare - Medical Instruments & Supplies Investor Relations →

YES
80.0% BELOW
↑ Moving away Was -80.2% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $15.53
14-Week RSI 18 📉
Rel. Volume (14w) This week's trading vs. the 14-week average 2.7x — Surging
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.73

Embecta Corp. (EMBC) closed at $3.11 as of 2026-06-19, trading 80.0% below its 200-week moving average of $15.53. This places EMBC in the extreme value zone. The stock moved further from the line this week, up from -80.2% last week. With a 14-week RSI of 18, EMBC is in oversold territory.

A big jump in activity this week — 2.7x the usual volume, and the price went up. Significantly more people than usual decided to buy. This kind of surge, especially on a stock already below its 200-week average, can be an early sign that sentiment is shifting.

Over the past 173 weeks of data, EMBC has crossed below its 200-week moving average 1 time. On average, these episodes lasted 169 weeks.

With a market cap of $185 million, EMBC is a small-cap stock. The company generates a free cash flow yield of 106.1%, which is notably high. The stock trades at -0.3x book value.

Share count has increased 2.5% over three years, indicating dilution.

Over the past 3.4 years, a hypothetical investment of $100 in EMBC would have grown to $11, compared to $197 for the S&P 500. EMBC has returned -47.4% annualized vs 22.0% for the index, underperforming the broader market over this period.

Free cash flow has been declining at a -22.3% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: EMBC vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After EMBC Crosses Below the Line?

Across 1 historical episodes, buying EMBC when it crossed below its 200-week moving average produced an average return of -51.0% after 12 months (median -51.0%), compared to +30.0% for the S&P 500 over the same periods. After 24 months, the average return was -54.0% vs +40.0% for the index.

Each line shows $100 invested at the moment EMBC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Dislocation Scores Experimental

Each score measures deviation from EMBC's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

3 stacked signals: drawdown, sector, value_vs_history
Yield Dislocation N/A Dividend yield vs own 10-yr norm
Drawdown Score +2.81σ Distance from line vs own history
Sector-Relative +2.60σ Vs sector median this week
Buyback Acceleration +0.6pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity N/A TTM buys / market cap, percentile of buyers
FCF Yield vs History +91.3pp Vs own recent annual mean
Earnings Quality Improving Accrual gap trend (-5.8pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Advertisement

Historical Touches

EMBC has crossed below its 200-week MA 1 time

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Mar 2023Ongoing169+80.5%Ongoing-87.4%

Frequently Asked Questions

Is EMBC below its 200-week moving average?

Yes. As of 2026-06-19, Embecta Corp. (EMBC) is trading 80.0% below its 200-week moving average of $15.53. The current price is $3.11.

What is EMBC's 200-week moving average price?

Embecta Corp.'s 200-week moving average is $15.53 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when EMBC drops below its 200-week moving average?

EMBC has crossed below its 200-week moving average 1 time in our data. These episodes lasted 169 weeks on average.

Is EMBC a good value right now?

Here's what our data says about EMBC as of 2026-06-19: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 18 (oversold). Free cash flow yield is 106.1%. Price-to-book is -0.3x. This is not a buy or sell recommendation — always do your own research.

How does EMBC compare to the S&P 500?

Over the past 3.4 years, $100 invested in EMBC would have grown to $11, compared to $197 for the S&P 500. That's -47.4% annualized vs 22.0% for the index. EMBC has underperformed the broader market over this period.

Does EMBC pay a dividend?

Yes. Embecta Corp. currently pays a dividend yield of 1481.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-06-19